GRCE

Grace Therapeutics, Inc. Common Stock
GRCE

Overview Fund Activity

27 hedge funds and large institutions have $6.67M invested in Grace Therapeutics, Inc. Common Stock in 2019 Q3 according to their latest regulatory filings, with 17 funds opening new positions, 1 increasing their positions, 4 reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
27
Holders Change
+14
Holders Change %
+107.69%
% of All Funds
0.59%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
17
Increased
1
Reduced
4
Closed
3
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
PP
Peconic Partners
New York
+$662K
2
Two Sigma Advisers
Two Sigma Advisers
New York
+$647K
3
Renaissance Technologies
Renaissance Technologies
New York
+$475K
4
MFS
Monetta Financial Services
Illinois
+$189K
5
OC
Oppenheimer & Co
New York
+$104K

Top Sellers

1
PVI
Pura Vida Investments
New York
-$380K
2
FDCDDQ
Federation des caisses Desjardins du Quebec
Quebec, Canada
-$69.8K
3
Morgan Stanley
Morgan Stanley
New York
-$65.5K
4
UBS Group
UBS Group
Switzerland
-$16.9K
5
Deutsche Bank
Deutsche Bank
Germany
-$7K
Name Holding Trade Value Shares
Change 		Shares
Change %
RE
26
RBC Europe
United Kingdom
$57 – – –
PVI
27
Pura Vida Investments
New York
– -$380K -6,940 Closed
Deutsche Bank
28
Deutsche Bank
Germany
– -$7K -130 Closed
Wells Fargo
29
Wells Fargo
California
– -$1K -21 Closed
1
2